...
首页> 外文期刊>European journal of clinical pharmacology >The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care
【24h】

The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care

机译:医院药物制剂政策对初级保健中质子泵抑制剂处方方式的影响

获取原文
获取原文并翻译 | 示例

摘要

Aim: This study had two aims: Firstly, to describe how prescriptions for proton pump inhibitor (PPI) in primary care were influenced by a change of the hospital drug policy, and secondly, to describe if a large discount on an expensive PPI (esomeprazole) to a hospital would influence prescribing patterns after discharge. Methods: This register study was conducted at Odense University Hospital, Denmark, and by use of pharmacy dispensing data and a hospital-based pharmacoepidemiological database, the medication regimens of patients were followed across hospitalisation. The influence of hospital drug policy on prescribings in primary care was measured by the likelihood of having a high-cost PPI prescribed before and after change of drug policy. Results: In total, 9,341 hospital stays in 2009 and 2010 were included. The probability of a patient to be prescribed an expensive PPI after discharge decreased from 33.5 to 9.4 %, corresponding to a risk ratio of 0.28. In primary care after discharge, 13.4 % of esomeprazole use was initiated in the hospital, and this was 8.4 % for PPIs in general. After the change of hospital drug policy, this decreased to 6.5 % for esomeprazole and increased for the recommended PPIs pantoprazole and lansoprazole to 14.6 and 26.1 %, respectively. The effect of a large discount on expensive PPI to hospital was 14.7 %, and this decreased to 2.6 % when coordinating drug policy in hospital and primary care. Conclusion: The likelihood of having an expensive PPI prescribed after hospital stay decreased when coordinating drug policy and the influence of a large discount to hospital could be minimised.
机译:目的:这项研究有两个目标:首先,描述医院药物政策的变化如何影响初级保健中质子泵抑制剂(PPI)的处方;其次,描述昂贵的PPI(埃索美拉唑)是否有较大折扣)到医院将影响出院后的处方方式。方法:该登记研究在丹麦欧登塞大学医院进行,并通过使用药房分配数据和基于医院的流行病学流行病学数据库,在整个住院期间对患者的用药方案进行了跟踪。医院药物政策对基层医疗处方的影响通过改变药物政策前后处方高成本PPI的可能性来衡量。结果:总共包括2009年和2010年的9,341住院次。出院后向患者开具昂贵的PPI的可能性从33.5%降低到9.4%,对应的风险比为0.28。在出院后的初级保健中,医院开始使用艾美拉唑的13.4%,一般而言,PPI的使用率为8.4%。改变医院药物政策后,埃索美拉唑的这一比率下降至6.5%,而推荐的PPI潘托拉唑和兰索拉唑的这一比率分别上升至14.6%和26.1%。大量折扣对昂贵的PPI到医院的影响为14.7%,当在医院和初级保健中协调用药政策时,这一影响降至2.6%。结论:在协调药物政策时,住院后处方昂贵的PPI的可能性降低,并且可以最大程度地降低对医院的折扣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号